Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of salmeterol powder with albuterol

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 2, 1999, Pages 205-211

  Blake, Kathryn ^a   Pearlman, David S ^b   Scott, Catherine ^c   Wang, Yonghua ^c   Stahl, Edmundo ^c   Arledge, Teresa ^c  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b Respiratory Institute   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL; SALMETEROL;

ARTICLE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; EXERCISE INDUCED ASTHMA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; TREATMENT OUTCOME;

EID: 0033041758     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62598-7     Document Type: Article

References (17)

1. Silverman M, Anderson SD. Standardization of exercise tests in asthmatic children. Arch Dis Child 1972;47: 882-889.
2. Kattan M, Keens TG, Mellis CM, Levison H. The response to exercise in normal and asthmatic children. J Pediatr 1978;92(5):718-721.
3. Silverman M, Konig P, Godfrey S. Use of serial exercise tests to assess the efficacy and duration of action of drugs for asthma. Thorax 1973;28: 574-578.
4. International consensus report on diagnosis and management of asthma. Bethesda, (MD): National Asthma Education Program, Office of Prevention, Education, and Control, National Heart, Lung, and Blood Institute, National Institutes of Health, 1992.
5. Anderson SD, Rodwell LT, Du Toit J, Young IH. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest 1991;100(5):1254-1260.
6. Boner AL, Spezia E, Piovesan P, et al. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med 1994;149:935-939.
7. Schaanning J, Vilsvik J, Henriksen AH, Bratten G. Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction. Ann Allergy Asthma Immunol 1996;76:57-60.
8. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child 1992;67:1014-1017.
9. Carlsen KH, Roksund O, Olsholt K, et al. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Eur Respir J 1995;8: 1852-1855.
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
11. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia (PA): Saunders, 1971.
12. Eggleston PA, Rosenthal RR, Anderson SA, et al. Guidelines for the methodology of exercise challenge testing of asthmatics. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy. J Allergy Clin Immunol 1979; 64:642-645.
13. van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bull Int Stat Inst 1958;37 (part 3):351-361.
14. Simons FE, Gerstner TV, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 1997;99:655-659.
15. Ramage L, Lipworth BJ, Ingram CG, et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994;88:363-368.
16. Yates DH, Worsdell M, Barnes PJ. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma. Am J Respir Crit Care Med 1997;156:988-991.
17. Simons FER. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. N Engl J Med 1997;337(23):1659-1665.